3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
10
Phase 1/2
4
Phase NA
3
Phase 2
3
Phase 4
2
Phase 3
2
Phase EARLY_PHASE1
1
Status
Recruiting
2
Withdrawn
1
Unknown
1
Sponsor Class
OTHER
1
INDUSTRY
1
Study Type
Interventional
2
Sponsor
Conditions
Breast Neoplasms
33
Neoplasms
17
Prostatic Neoplasms
14
Lung Neoplasms
12
Carcinoma, Hepatocellular
11
Carcinoma, Non-Small-Cell Lung
10
Multiple Myeloma
9
Colorectal Neoplasms
9
Precursor Cell Lymphoblastic Leukemia-Lymphoma
6
Papillomavirus Infections
6
Pain, Postoperative
6
Neoplasm Metastasis
6
Leukemia, Myeloid, Acute
6
Stomach Neoplasms
5
Recurrence
5
Liver Neoplasms
5
Lymphoma, Non-Hodgkin
4
Kidney Neoplasms
4
Heart Failure
4
Glioma
4
Febrile Neutropenia
4
Carcinoma, Renal Cell
4
Brain Neoplasms
4
Warts
3
Uterine Cervical Neoplasms
3
Urinary Bladder Neoplasms
3
Skin Neoplasms
3
Rectal Neoplasms
3
Pituitary Neoplasms
3
Pancreatic Neoplasms
3
Interventions
Rituximab
1
Control Groups
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 4
×
Recruiting
×
Epstein-Barr Virus Infections
×
Clear all
NCT04308278
2024-10-30
EBVAST
Labo'Life
Phase 4
Recruiting
88 enrolled
NCT04989491
2024-08-19
REPLY
University Hospital, Strasbourg, France
Phase 4
Recruiting
120 enrolled